-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse NYSE New York Stock ExchangeSymbol RDY
Zahlte zuletzt am 08.07.2021 eine Dividende von 0,342 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Dr. Reddy’s Laboratories Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Dr. Reddy’s Laboratories Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Dr. Reddy’s Laboratories Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Dr. Reddy’s Laboratories Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
35 News & Informationen zur Dr. Reddy’s Laboratories Limited Aktie
Panacea Biotec To Manufacture Up To 25 Mn Doses Of Sputnik V Vaccine
Panacea Biotec shall produce the Sputnik V vaccine using the ready-to-fill drug substance manufactured by Generium in Russia, and then supply the entire quantity to Dr Reddy's for distribution in India, , Sputnik V vaccine, panacea biotec, manufacturing
Panacea Biotec to manufacture up to 25 mn doses of Sputnik V vaccine
Read more about Panacea Biotec to manufacture up to 25 mn doses of Sputnik V vaccine on Business Standard. Shares of Panacea Biotec ended at Rs 356.40 per scrip on BSE, up 2.77 per cent from its previous close.
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q1 2021 Results – Earnings Call Transcript
Dr. Reddy's Laboratories Limited (NYSE:RDY) Q1 2021 Earnings Conference Call July 27, 2021 08:00 AM ET Company Participants Amit Agarwal – Head, Investor Relations & Director, Finance,…
Dr Reddy's Q1 results: Net profit falls 1% to Rs 571 cr, revenue up 11%
Dr Reddy's said it has launched Russia's Sputnik V vaccine in India across 80 cities, and over 2.5 lakh people have been vaccinated so far.
Dr Reddy's shares tumble over 10 per cent post earnings announcement
Dr Reddy's reported a 36 per cent decline in consolidated net profit for the quarter ended June 30, 2021
Dr Reddy's says investigating bribery allegations against it, in Ukraine and other CIS countries
Taking Stock: Indian indices fall on weak Asian cues; pharma worst hit
On the BSE, healthcare and power indices lost 1.5-3 percent, while the metal index added 1.6 percent
Share market update: Most active stocks of the day in terms of traded value
The NSE Nifty index closed 78.0 points down at 15746.45
Dr Reddy's Labs Sheds 11% After Profit Falls 1.5% To Rs 570 Crore In June Quarter
Dr Reddy's Share Price Today: On Tuesday, Dr Reddy's Labs opened on the BSE at Rs 5,421, inching to an intra day high of Rs 5,445, and an intra day low of Rs 4,786.26, so far
Dr Reddy Laboratories : . Reddy's Q1 FY22 Financial Results
Press Release
… | July 27, 2021
Dr Reddy's Laboratories share price falls 3% post June quarter result
The share touched a 52-week high of Rs 5,613.65 and a 52-week low of Rs 3,963.85 on 07 July, 2021 and 27 July, 2020, respectively.
Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
Revenue from operations grew by 11.4 percent year-on-year to Rs 4,919.4 crore in Q1FY22
Share market update: Most active stocks on D-Street today in terms of volume
The NSE Nifty index was trading 50.65 points up at 15875.1
Buzzing Stocks: L&T, Axis Bank, Tata Motors and other stocks in news today
Stocks In the News: Check out the companies making the biggest headlines before the opening bell.
Trade setup for Tuesday: Top 15 things to know before Opening Bell
Nagaraj Shetti of HDFC Securities feels the short term trend of Nifty is choppy and similar movement could be expected for the next session.
Glenmark Life Sciences IPO opens on July 27: 10 things to know before the issue
Glenmark Life Sciences IPO: The company plans to raise Rs 1,497.85 crore at the lower end and Rs 1,513.6 crore at the higher end of the price band.
Sputnik V soft launched in over 50 cities in India: Dr Reddy's
Sensex, Nifty Follow Asian Peers Higher
(RTTNews) – Indian shares opened a tad higher Tuesday on the back of positive cues from other Asian markets after Chinese export data topped forec…
2 Top Global Value Stocks to Buy Now
Don't want to pay too steep a price for high-quality stocks? Look abroad.
Hot Stocks | Can bet on Dr. Reddy's Labs, HDFC Bank and Hindalco for the short term
Near-term support for Nifty is placed near the 15,650 level and once the previous high of 15,915 is sustainably breached, it could rise towards the 16,000 mark and even higher, said xx of Bonanza Portfolio
10 trading ideas for the next 3-4 weeks that could return 5-13%
On the upside, stiff resistance is placed at 15900-16000. While on the downside, supports are placed at 15650-15450, suggest experts.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs.
Interesting Facts: The largest company by market cap to set a new 52-week high was …
Dr Reddy Laboratories : Annual Return
FORM NO. MGT-7
[Pursuant to sub-Section of section 92 of the Companies Act, 2013 and sub-rule of rule 11of the Companies … | July 2, 2021
These 6 picks by technical experts can give 10-50% return over the next 3-6 months
If the Nifty slides here on, 15,400 will be the decisive support and a breach will drag the index towards 15,000 that could again be a buying opportunity, say experts.
Stocks That Hit 52-Week Highs On Thursday
This morning 158 companies set new 52-week highs.
Intriguing Points: NVIDIA (NASDAQ:NVDA) was the largest firm on a market cap basis to set a …
Sensex, Nifty End Lower For 4th Straight Day
(RTTNews) – Indian shares ended weak on Thursday, weighed down by worries about the surge in the delta variant of the coronavirus cases across the…
Dr. Reddy's Laboratories Announces Filing Of Annual Report On Form 20-F
Dr. Reddy's Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as
Stocks to watch: Vodafone Idea, SpiceJet, Union Bank, Dish TV, auto stocks
Read more about Stocks to watch: Vodafone Idea, SpiceJet, Union Bank, Dish TV, auto stocks on Business Standard. Shares of auto companies will be in focus as firms will release their sales figures for the month of June
B Medical Systems joins hands with Dr Reddy's for pan-India rollout of Sputnik V vaccines
Under the collaboration, the company will install several hundreds of vaccine freezers across the country for the national roll-out of Sputnik V vaccines, B Medical Systems said in a statement.
Dr Reddy's launches DRDO's COVID-19 drug 2-DG, priced at Rs 990
In the initial weeks, the company will make the drug available in hospitals across metros and tier-1 cities, and subsequently the coverage will be expanded to the rest of India.
Sensex, Nifty End Modestly Lower
(RTTNews) – Indian shares gave up early gains to end modestly lower on Monday, with rising oil prices, mixed signals from Fed officials on the rat…
Dr Reddy's Labs share price gains over launch of COVID-19 treatment drug
In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India, the company said in an exchange filing.
Why Amarin Fell Again Today
Another Vascepa generic is launched in the U.S.
Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US
Shares of Dr Reddy's were trading 0.14 per cent lower at Rs 5,272.05 apiece on the BSE., , dr reddy, usfda, Ethyl Capsules, shares
Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US
Icosapent Ethyl Capsules, used to reduce triglyceride levels in adult patients have been launched by Dr. Reddy's Laboratories in the US market.